Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](GeneScience Pharmaceuticals Co., Ltd.)"
Count: 56
Selected: 0
NCT IDTitle
NCT01785784Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn
NCT02375620Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
NCT03245333A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)
NCT03221933A Study of Recombinant Human Growth Hormone Injection(JINTOPIN AQ)for Short Children With Small for SGA
NCT03535415A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
NCT03189160A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
NCT03554031A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
NCT03635580Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS
NCT02908958Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT03071172Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
NCT03255694A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
NCT03221088A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
NCT03104010A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD
NCT04053205A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer
NCT03249480Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT06204250A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers
NCT06189495A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
NCT06135168A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
NCT06135155A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
NCT06133166A Study for the Treatment of Dry Eye in Postmenopausal Women
NCT06095206The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site
NCT06091436To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
NCT06024967A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency
NCT06007417A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
NCT05983445Safety & Efficacy of Genakumab in Patients With Frequent Flares
NCT05936281Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
NCT05936268Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
NCT05925452To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
NCT05921890To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.
NCT05919381Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.
NCT05894148Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults
NCT05674045A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
NCT05673694To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
NCT05611281GS3-007a Oral Solution in Healthy Subjects
NCT05441046Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
NCT05353192A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05328531Clinical Study of Genakumab for Injection in Patients With Acute Gout
NCT05263271Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
NCT05223595A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
NCT05221385Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
NCT04337437Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers
NCT03313219Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China
NCT03290235Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
NCT02976675Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02801591Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET
NCT02801565Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
NCT02380235Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
NCT02335879Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
NCT02314676Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
NCT01613573Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children